{
    "root": "2f2287fd-5588-83a4-e063-6294a90af829",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Sulfasalazine",
    "value": "20250227",
    "ingredients": [
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "SULFASALAZINE",
            "code": "3XC8GUZ6CB"
        }
    ],
    "indications": "sulfasalazine tablets indicated : treatment mild moderate ulcerative colitis , adjunctive therapy severe ulcerative colitis ; prolongation remission period acute attacks ulcerative colitis",
    "contraindications": "sulfasalazine tablets adjusted individual 's response tolerance .",
    "warningsAndPrecautions": "sulfasalazine tablets , 500 mg , round , gold-colored , scored tablets , monogrammed `` g500 `` . available following package sizes : ndc : 70518-1829-00 ndc : 70518-1829-01 ndc : 70518-1829-02 ndc : 70518-1829-03 ndc : 70518-1829-04 packaging : 270 1 bottle plastic packaging : 30 1 blister pack packaging : 30 1 blister pack packaging : 30 1 blister pack packaging : 270 1 bottle plastic store 25° c ( 77° f ) ; excursions permitted 15–30° c ( 59–86° f ) [ usp controlled room temperature ] . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "sulfasalazine tablets contraindicated : patients intestinal urinary obstruction , patients porphyria sulfonamides reported precipitate acute attack , patients hypersensitive sulfasalazine , metabolites , sulfonamides , salicylates .",
    "indications_original": "Sulfasalazine tablets are indicated:\n                  \n                     in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and\n                     for the prolongation of the remission period between acute attacks of ulcerative colitis",
    "contraindications_original": "The dosage of sulfasalazine tablets should be adjusted to each individual's response and tolerance.",
    "warningsAndPrecautions_original": "Sulfasalazine tablets, 500 mg, are round, gold-colored, scored tablets, monogrammed \"G500\". They are available in the following package sizes:\n                  \n                  NDC: 70518-1829-00\n                  NDC: 70518-1829-01\n                  NDC: 70518-1829-02\n                  NDC: 70518-1829-03\n                  NDC: 70518-1829-04\n                  PACKAGING: 270 in 1 BOTTLE PLASTIC\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 270 in 1 BOTTLE PLASTIC\n                  \n                  Store at 25° C (77° F); excursions permitted to 15–30° C (59–86° F) [see USP Controlled Room Temperature].\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Sulfasalazine tablets are contraindicated in:\n                  \n                     Patients with intestinal or urinary obstruction,\n                     Patients with porphyria as sulfonamides have been reported to precipitate an acute attack,\n                     Patients hypersensitive to sulfasalazine, its metabolites, sulfonamides, or salicylates."
}